Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - azoxystrobin; cyproconazole - suspension concentrate - azoxystrobin pyrimidine active 200.0 g/l; cyproconazole triazole active 80.0 g/l - fungicide - barley | peanut | wheat - early leaf spot on peanut | late leaf spot on peanut | leaf rust | net blotch | net form of net blotch | powdery mildew on barley | powdery mildew on wheat | rust | spot form net blotch - pyrenophora teres | stripe rust | yellow leaf spot on wheat | puccinia recondita f.sp. triti | puccinia triticina | wheat leaf rust | yellow spot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - diquat present as diquat dibromide monohydrate; diquat present as diquat dibromide monohydrate; paraquat present as paraquat dichloride; paraquat present as paraquat dichloride; polyethanoxy (15) tallow amine - soluble concentrate - diquat present as diquat dibromide monohydrate pyridine-bipyridyl active 115.0 g/l; diquat present as diquat dibromide monohydrate pyridine-bipyridyl active 115.0 g/l; paraquat present as paraquat dichloride pyridine-bipyridyl active 135.0 g/l; paraquat present as paraquat dichloride pyridine-bipyridyl active 135.0 g/l; polyethanoxy (15) tallow amine emulsifiers & surfactants other 30.0 g/l - herbicide - around established trees | avocado | banana | canola oilseed crop | clover pasture | cocksfoot | cotton | custard apple | demete - african turnip weed - seedling | annual broadleaf weed | annual grass weed | annual saltbush - seedling | annual weeds | australian bindweed | australian bindweed - seedling | australian bluebell - seedling | awnless barnyard grass - seedling | barnyard grass or water grass | barnyard or water grass | barnyard or water grass - seedling | bathurst burr - seedling | bellvine - seedling | black pigweed - seedling | blackberry nightshade - seedling | bladder ketmia | bladder ketmia - seedling | blue top - ageratum/heliotropium spp. | boggabri weed - seedling | broadleaf weeds | broadleaf weeds - see label | buffel grass - seedling | calopo | caltrop or yellow vine | caltrop or yellow vine - seedling | capeweed | caustic weed - seedling | cereal - self-sown | climbing buckwheat - seedling | clover | columbus grass - seedling | common heliotrope | cowvine - seedling | cudweed - seedling | deadnettle - seedling | erodium, crowfoot or storksbill | european bindweed - seedling | fat hen - seedling | fireweed - seedlin

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - fludioxonil - suspension concentrate - fludioxonil phenylpyrrole active 125.0 g/l - fungicide

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.935 mg; telmisartan, quantity: 40 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.87 mg; telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.935 mg; telmisartan, quantity: 80 mg - tablet, uncoated - excipient ingredients: sodium hydroxide; meglumine; povidone; magnesium stearate; citric acid; mannitol; colour - treatment of hypertension. treatment should not be initiated with this fixed-dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - flumazenil, quantity: 1 mg - injection, solution - excipient ingredients: disodium edetate; sodium chloride; water for injections; sodium hydroxide; glacial acetic acid - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - flumazenil, quantity: 0.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; disodium edetate; glacial acetic acid; sodium chloride - flumazenil-baxter is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil-claris. not to be used in outpatients or short stay patients. not to be used as a diagnostic.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - flumazenil, quantity: 0.5 mg - injection, solution - excipient ingredients: disodium edetate; water for injections; sodium hydroxide; sodium chloride; acetic acid - dbl flumazenil injection is indicated for use in hospitalised patients for the reversal of acute benzodiazepine effects (overdose or therapeutic). hospitalised patients are patients admitted to hospital, inpatient care and under continued professional observation while under the influence of flumazenil. not to be used in outpatients or short stay patients. not to be used as a diagnostic.